<DOC>
	<DOC>NCT00392002</DOC>
	<brief_summary>To characterize the burden of disease in GERD patients of prescription therapy'</brief_summary>
	<brief_title>Examine National Characteristics &amp; Outcome Measures of GERD Patients Using the PPI Acid Suppression Symptom (PASS) Test for Response</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Signed informed consent, 18 years or older, diagnosis of GERD Peptic ulcer disease, upper gastrointestinal surgery, malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>GERD</keyword>
</DOC>